Life Science Cares, Inc. – Trademark Portfolio
Entity Type: 99
Life Science Cares, Inc. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 41 (Education & Entertainment) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include PROJECT ONRAMP and LIFE SCIENCE CARES. The owner is based in Boston, MA.
P.O. Box 425486
Boston, MA 02142
Showing of trademarks Trademarks
Trademark Classifications
Life Science Cares, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Education; providing of training; entertainment; sporting and cultural activities
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Life Science Cares, Inc. have?
Life Science Cares, Inc. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Life Science Cares, Inc. file in?
Life Science Cares, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 41 (Education & Entertainment), Class 35 (Advertising & Business), Class 36 (Insurance & Financial). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.
What are Life Science Cares, Inc.'s most well-known trademarks?
Life Science Cares, Inc.'s registered trademark portfolio includes well-known marks such as PROJECT ONRAMP and LIFE SCIENCE CARES. These are among 3 currently registered trademarks in the portfolio.
What is Life Science Cares, Inc.'s trademark registration success rate?
Life Science Cares, Inc. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.